
The Frontier X Plus is designed with reliability, safety, and performance at its core, ensuring precise, high-quality cardiac monitoring. Its FDA clearance reinforces its safety standards, giving you confidence in its use for arrhythmia detection and remote monitoring applications. Built with secure data transmission and encryption, it ensures patient information remains protected at all times.

The Frontier X Plus is designed with reliability, safety, and performance at its core, ensuring precise, high-quality cardiac monitoring. Its FDA clearance reinforces its safety standards, giving you confidence in its use for arrhythmia detection and remote monitoring applications. Built with secure data transmission and encryption, it ensures patient information remains protected at all times.
Technical Safety and Performance Testing
Frontier X Plus Device
- IEC 60601-2-47:2014 Medical Electrical Equipment Part 2-47: Particular Requirements for the safety. Including essential performance of ambulatory electrocardiographic systems.
- IEC 60601-1:2005, AMD1:2012 Medical Electrical equipment - Part 1:General requirements for basic safety and essential performance.
- IEC 60601-1-2:2014 +AMD1: 2020 CSV, Medical Electrical Equipment - Part 1-2: General requirements for basic safety and essential performance - Collateral standard: Electromagnetic disturbances Requirements and tests.
- IEC 60601-1-11:2015 Medical Electrical Equipment - Part 1-11: General requirements for basic safety and essential performance - Collateral standard: Requirements for medical electrical equipment and medical electrical systems used in the home healthcare environment.
Chest Strap
- Compliant with REACH and RoHS2 standards.
Clinical Validation
This study aimed to validate the Frontier X Plus (FX+) single-lead, continuous ECG device by comparing its performance against the traditional FDA Cleared 12-lead ECG in 832 patients in both a clinical and real world setting including individuals with and without atrial fibrillation (AFib). The performance of the Frontier X Plus in detecting atrial fibrillation (AF) demonstrated a sensitivity of 98.10% and a specificity of 97.88%, when compared to the paired gold standard device as adjudicated by 3 independent cardiologists.


Note:>
The Frontier X Plus (FX+) is a prescription only US FDA 510(k) cleared medical device for ambulatory ECG monitoring. It is not tested for use in individuals with pacemakers or ICDs. It is not meant for the diagnosis of cardiac ischemia. Please request the IFU for intended use, indications, contraindications and availability in your geography.
Disclaimer: All images used are for illustrative purposes only.